Procainamide Hydrochloride

CHEMBL605 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
271.8 g/mol
LogP
Phase
4

A hydrochloride salt form of procainamide with the same therapeutic properties. Used to treat certain abnormal heart rhythms (arrhythmias) by slowing electrical conduction in the heart and making the heart muscle less excitable.

Berat Molekul

271,7800 g/mol

TPSA

58,40 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)CCNC(=O)c1ccc(N)cc1.Cl

InChI

InChI=1S/C13H21N3O.ClH/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11;/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17);1H

Molecular Formula

C13H22ClN3O

HBD / HBA

3 / 3

Ikatan yang Dapat Dirotasi

6

Atom Berat

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A hydrochloride salt form of procainamide with the same therapeutic properties. Used to treat certain abnormal heart rhythms (arrhythmias) by slowing electrical conduction in the heart and making the heart muscle less excitable.

Yes, Procainamide Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL605. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 66068. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.